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Abstract 
Bovine lens aldose reductase is susceptible to a copper mediated oxidation, leading to the 
generation of a disulfide bridge with the concomitant incorporation of two equivalents of the 
metal and inactivation of the enzyme. The metal complexed by the protein remains redox-
active, being able to catalyze the oxidation of different physiological thiol compounds. The 
thiol oxidase activity displayed by the enzymatic form carrying one equivalent of copper ion 
(Cu1-AR) has been characterized. The efficacy of Cu1-AR in catalyzing thiol oxidation is 
essentially comparable to the free copper in terms of both thiol concentration and pH effect. 
On the contrary, the two catalysts are differently affected by temperature. The specificity of 
the AR-bound copper towards thiols is highlighted being Cu1-AR completely ineffective in 
promoting the oxidation of both low density lipoprotein and ascorbic acid.  
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Introduction 
The role of transition metals in inducing cell damage has been widely recognized [1, 2]. 
They promote the generation of reactive oxygen species (ROS), thus leading to oxidative 
stress which represents a co-causative factor in several pathological states linked to proteins, 
lipids and nucleic acid damage [3-8]. 
Copper ion is one of the most active transition metals in eliciting ROS generation. Given 
that it is the cofactor of several enzyme systems [9, 10], copper plays an important role as a 
trace element, thus making its deficiency detrimental for living cells [11, 12]. On the other 
hand, the fact that copper promotes ROS production through the Fenton reaction, means that 
it is important to control cellular levels of copper to prevent metal toxicity.  
Several protein systems (i.e. transporter, storage proteins and Cu-chaperones) have thus 
evolved to regulate the uptake, distribution and delivery of copper [13-17]. Despite this strict 
control, diseases characterized by abnormally either elevated or low copper levels have been 
described, such as Wilson or Menkes disease, respectively [18]. Recently it has been 
postulated that elevated free copper levels may predict the risk for the onset of diabetes and 
Alzheimer disease [19].  
The binding of copper to proteins normally warrants the maintenance of the metal in a redox 
inactive form, in order to avoid metal-catalyzed oxidation of cell components. However, pro-
oxidant features of copper-binding proteins, such as superoxide dismutase, caeruloplasmin and β-
amyloid, have been documented [20-23]. 
Despite not being a metal binding protein, aldose reductase (alditol: NADP
+
oxidoreductase, 
EC 1.1.1.21) (AR) is extremely sensitive to Cu(II), which overall seems to act as a tightly 
binding modifying agent. In fact, AR from bovine lens has been shown to be readily 
inactivated in the presence of stoichiometric amounts of the metal through an oxygen 
independent modification [24]. The loss of activity relies on the formation of a disulphide 
bridge between Cys298 and Cys303, and is accompanied by the incorporation of two 
equivalents of copper per enzyme mol [24, 25]. Molecular modelling studies [25] indicated 
that, of these two copper ions, one was completely embedded in the protein, while the other 
resulted free to interact with water molecules. Moreover, these studies suggested an active 
role of Thr113, Trp111 and Leu 300 in the interaction between AR and the copper ion 
embedded in the protein structure. These predictions were consistent with the observation 
that only one of the two copper ions can be detected by direct bathocuproine titration, while 
the second copper ion resulted accessible to bathocuproine only after prolonged thermal 
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treatment of the copper-modified AR in the presence of either reducing or chelating agents 
[24].  
In this paper, we report that the copper bound to AR remains redox active toward thiol 
compounds, but not toward other copper sensitive targets (i.e. ascorbic acid and low density 
lipoprotein), thus making the copper-modified AR able to act as a thiol oxidase.  
 
Materials and Methods 
Materials 
Bathocuproinedisulfonic acid (BCDS), cysteine, CysGly, dithiothreitol (DTT), reduced 
glutathione (GSH), glutathione disulfide (GSSG), homocysteine, human low density 
lipoprotein (LDL), NADPH, penicillamine, monothioglycerol, γ-glutamylcysteine, 
cysteamine, thiobarbituric acid (TBA), D,L-glyceraldehyde (GAL), ascorbic acid (AA), 
ascorbate oxidase from Cucurbita sp (E.C. 1.10.3.3) were from Sigma-Aldrich. All other 
chemicals were of reagent grade from BDH Chemicals.  
Enzymatic assay and purification of aldose reductase. Aldose reductase activity was 
measured at 37°C as previously described [26] using GAL as a substrate.  
The enzyme was purified from bovine lens as previously described [27]. The pure enzyme 
(1.2 U/mg) was stored at 4°C in 10 mM sodium phosphate buffer pH 7.0 (S-buffer) 
containing 2 mM DTT. The molar concentration of AR was calculated on the basis of a 
molecular mass of 34 kDa, and of the protein concentration determined by the Coomassie 
Blue binding assay [28] performed using bovine serum albumin as a standard.  
Preparation of copper-modified AR. The copper-modified AR was prepared as described 
[24], by incubating at 25°C in the S-buffer the purified bovine lens enzyme (3.5 μM final 
concentration), after an extensive dialysis against the S-buffer, in the presence of a 2.5 fold 
molar excess of CuCl2. After 90 min of incubation, the enzyme (which displayed a residual 
activity of about 15% compared to the native enzyme) was again dialyzed against S-buffer 
and stored at 4°C for no more than two days. As expected [24], this enzyme form (Cu2-AR) 
contained two equivalents of copper as determined by complexometric titration (see below). 
Preparation of glutathione-modified aldose reductase. AR carrying a mixed disulphide with 
glutathione at the level of Cys298 (GS-AR) was prepared as previously described [29] upon 
incubation of 3.5 μM native AR for 3 h at 25°C with 1.5 mM GSSG, followed by extensive 
dialysis against the S-buffer. 
Evaluation of LDL oxidation. LDL oxidation was detected essentially according to Yagi 
[30]. LDL was suspended (2 mg/mL) in S-buffer and then dialyzed against the same buffer 
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in order to remove the ethylenediamine tetraacetic acid (EDTA) present in the commercial 
preparation. Dialyzed LDL was incubated (70 μg/mL) in S-buffer at 37°C alone or in the 
presence of 1μM of either CuCl2 or Cu1-AR. At appropriate times (from 0 to 5 h), aliquots 
of 400 μL were withdrawn and 10 μL of 10 mM EDTA and 1 mL of 10% trichloroacetic 
acid were added. After the addition of 1 mL of 0.67 % TBA, samples were incubated at 
95°C for 2 h and, after cooling, the fluorescence at 554 nm (excitation 525 nm) was 
measured on a Jasco FP6500 spectrofluorimeter. 
Other methods. The concentration of thiol compounds was determined by Ellman titration 
[31]. 
Copper concentration was determined by BCDS titration as previously described [24] using an 
extinction coefficient for the (BCDS)2Cu(I) complex of of 12,250 M
-1
cm
-1
, which was evaluated by 
calibration curves obtained using standard CuCl2 solutions. When the metal was measured on Cu-
treated AR, the increase in absorbance at 483 nm was followed at 25 °C until no more increase was 
observed (approximately 120 min). Calculation was done after subtraction of absorbance values 
observed for control samples containing the same concentration of native AR. 
The concentration of ascorbic acid was determined by evaluating the decrease in the 
absorbance at 265 nm following the oxidation of AA upon the addition of 250 mU of 
ascorbate oxidase. The extinction coefficient at 265 nm, obtained using known concentration 
of ascorbic acid, was 12.6 ± 0.9 mM
-1
cm
-1
. 
Unless otherwise stated, all the data are expressed as the mean ± standard deviation of at 
least four independent measurements. Statistical analysis was performed using GraphPad 6.0 
Software. 
 
RESULTS AND DISCUSSION 
 
Thiol oxidase ability of copper-modified AR 
An important aspect of the oxidative modification of AR induced by Cu(II) is the retention 
by the oxidized enzyme of two equivalents of copper, which are bound to the protein (Cu2-
AR) with a different level of efficiency [24, 25]. In our study, while one copper ion was 
released in solution after the incubation of 3.5 µM Cu2-AR at 25 °C in S-buffer for 2 h, the 
second metal ion was removed from the protein only by a dialysis against the S-buffer 
performed after a prolonged incubation (at least 3 h) at 37°C in the presence of 5 mM DTT. 
Both modifications occurring on AR upon Cu(II) treatment (i.e. the binding of the metal ion 
and the oxidation of protein thiols) were thus reversed.  
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When 1 µM Cu2-AR was incubated at 25° C in S- buffer with 1 mM cysteine, there was a 
decrease in the reduced thiol, evaluated by DTNB titration (Fig. 1). There was no significant 
oxidation of cysteine with either 1 µM native AR or with a solution obtained after protein 
removal by ultrafiltration through an Amicon YM10 membrane of a freshly prepared 1 µM 
Cu2-AR. The oxidation rate (29 ± 4 µM/min) was approximately twofold the value 
measured, under the same conditions, with 1 µM CuCl2 (14 ± 1 µM/min). These results 
suggest that both copper ions of Cu2-AR remained active as catalysts of thiol oxidation. 
The removal of one copper ion upon incubation of Cu2-AR at 25°C for 2 h followed by 
dialysis against S-buffer led to the generation of an enzyme form carrying only one (1.0 ± 
0.1) copper ion per enzyme mol (Cu1-AR), as evaluated by complexometric analysis, which 
was still able to induce cysteine oxidation (Fig. 1). A rate of cysteine oxidation of 13 ± 2 
µM/min was measured with 1 µM Cu1-AR, which was comparable with that measured the 
presence of 1 µM CuCl2. 
In order to evaluate the contribution of protein moiety on the thiol oxidase ability of AR, the 
second copper ion was removed in not reducing conditions by dialysis against S-buffer after 
a prolonged incubation (3 h at 37°C) in S-buffer containing 1 mM EDTA (data not shown). 
In this case, the removal of the metal left AR in an inactive status, both as aldose reductase 
and as thiol oxidase (Fig. 1). When this copper-depleted enzyme was incubated (3.5 µM) 
with CuCl2 (8.75 µM) at a ratio of approximately 1 to 3, it was able to bind approximately 
two (1.8 ± 0.2) equivalents of the metal per enzyme mol, thus regaining its ability to 
catalyze cysteine oxidation (data not shown). These results highlight the importance of 
copper as the triggering species for thiol oxidation, as the oxidized AR is simply a protein 
scaffold that reversibly binds the metal ion.  
The significance of the disulphide between Cys298 and Cys303 occurring in Cu1-AR [25] 
for copper binding was tested using the glutathionylated AR. This enzyme form (GS-AR), 
characterized by the S-glutathionylation at Cys298 [32], the most accessible Cys residue of 
AR, generated by GSSG transthiolation on AR (see Methods) and found in the bovine lens 
undergoing oxidative stress [33], was used as a protein target for Cu(II) oxidation. The 
incubation for 2 h of 3.5 μM GS-AR at 25°C in the presence of a 2.5 molar excess of CuCl2 
led to a progressive inactivation of the enzyme, as occurred for the native AR (data not 
shown).  
Copper evaluation on the inactive enzyme revealed the presence of approximately one (1.1 ± 
0.2) equivalent of the metal ion per enzyme mol. When copper-modified GS-AR was used 
as a catalyst of CysGly oxidation, oxidation rates of 11 ± 1 µM/min were measured, which 
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were essentially the same values observed for equivalent concentrations of free copper in 
solution. This suggests that the structural restraints linked to the intramolecular disulphide 
on Cu1-AR are not a key factor in copper binding.  
 
Kinetic features of thiol oxidation catalyzed by Cu1-AR 
Due to the relatively easy release of the first copper ion from Cu2-AR, it is conceivable that 
this copper ion may leave the enzyme, either wholly or partially, while acting as thiol 
oxidase and may exert its oxidant ability in solution. Thus, in order to evaluate the oxidant 
ability of the AR bound metal, Cu1-AR was used in further experiments. It is conceivable 
that the copper remaining in Cu1-AR was the ion that molecular modelling studies predicted 
as completely embedded in the protein structure [25]. The possible release of copper from 
Cu1-AR during incubation with different thiol compounds was tested and ruled out. In fact, 
the same rate of oxidation of cysteine was observed using both freshly prepared Cu1-AR and 
Cu1-AR recovered after the enzyme had been used as a catalyst of the complete oxidation of 
1 mM cysteine and then dialyzed against S-buffer. 
Different thiols showed a different susceptibility to oxidation by Cu1-AR, as occurs when 
using the free copper in solution. Also the pH, as expected, affects the oxidation, being pH 8 
the optimal condition for oxidation for most of the tested thiols, except for cysteine and Cys-
Gly, whose maximal oxidation rates were observed at pH 7.4 and 6.5, respectively. Table 1 
reports the oxidation rates measured for different thiol compounds when incubated at 25°C 
at their optimal pH with 1 µM of either Cu1-AR or CuCl2. For both catalysts, the values 
ranged within more than one order of magnitude between the oxidation rate of glutathione 
and homocysteine and the oxidation rate of cysteamine. The results underline the similarity 
of the thiol oxidative process in the presence of the two oxidation inducers (i.e. Cu1-AR and 
free copper ion). The only exception concerns Cys-Gly, which appeared to be slightly more 
susceptible to the oxidation induced by Cu1-AR compared to CuCl2 (29 ± 5 µM/min versus 
18 ± 2 µM/min). This difference was constantly observed at different pH values and at 
different concentrations (ranging from 0.25 to 2 μM) of both free and AR-bound copper 
(data not shown). 
The substrate dependence of thiol oxidation catalyzed by Cu1-AR and CuCl2 was evaluated 
using cysteine as a target. The oxidation rate of cysteine increased with increasing thiol 
concentration, reaching an apparent saturation, as reported in Fig. 2. An apparent KM of 1.3 
± 0.1 (SE) mM and a Vmax of 25 ± 3 (SE) µM/min were measured with 0.8 µM Cu1-AR. A 
similar result was obtained when 0.8 µM CuCl2 was used as catalyst. In this case, a 
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concentration of cysteine leading to a half saturation of the oxidative process of 1.0 ± 0.1 
(SE) mM and a maximal rate of oxidation of 28 ± 1 (SE) µM/min were measured.  
Temperature appeared to be the most effective parameter in discriminating the free copper 
from the AR-bound copper dependent thiol oxidation. The oxidation rate of cysteine was 
evaluated at temperatures in the range 25-40°C, using both Cu1-AR and CuCl2 as catalysts 
(Fig. 3). In the range 20-33°C, no differences were observed between the two catalysts. 
When the temperature was increased above 33°C, the oxidation rate in the presence of Cu1-
AR diverges, at 40°C reaching a value (44 ±1 µM/min) that accounts for an overall four-fold 
increase compared to the value measured at 25°C. In the same conditions, the increase in 
temperature from 25 to 40°C in the presence of CuCl2 led to an increase in the rate of 
cysteine oxidation of only 1.3 fold.  
Thiol oxidation induced by copper proceeds through the preliminary formation of complexes 
with different low molecular weight ligands, including the same thiol undergoing oxidation 
[34-37]. It is conceivable that the intramolecular copper complex characterizing Cu1-AR is 
more stable than the intermolecular complexes that copper may form with cysteine 
undergoing oxidation, which may explain the observed difference. 
 
Target specificity of the oxidase activity of copper-bound AR 
The ability of copper bound to AR to act as a catalyst of the oxidation of other molecules, 
different from thiols, was investigated. The susceptibility of LDL to oxidative modification 
by Cu(II), a key step in the aetiology of atherosclerosis, is a well-known event, although the 
conditions governing the oxidative process are still under investigation [38-41]. Ascorbic 
acid is another target of copper dependent oxidation [42, 43]. In fact, ascorbic acid and 
Cu(II) represent a pro-oxidant cell-damaging system, in which the reducing features of 
ascorbic acid enhance the redox potential of the metal ion, thus favouring, in the presence of 
oxygen, ROS generation [44, 45]. Both LDL and ascorbate were used as targets to compare 
the oxidative trigger effect exerted by the free copper ion and the AR-bound metal. LDL and 
ascorbic acid were incubated with either CuCl2 or Cu1-AR, at a final concentration of 1 µM. 
The results reported in Figs. 4 a and b clearly show the complete inability of Cu1-AR to 
catalyze the oxidation of both LDL and ascorbic acid. Besides the oxidation potential of the 
metal ion bound to AR, as judged by its ability to oxidize thiols, it is evident that its action 
may be restricted. In particular, it is relevant that, when reduced thiols are added to copper 
modified AR, the generation of a mixed disulphide between the thiol and Cys298 has been 
described [25]. Thus, it is conceivable that this may be the first step in the interaction 
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between Cu1-AR and the thiol compound and may represent the only way for a molecule to 
interact with a copper ion which is completely embedded in the protein scaffold. The copper 
ion trapped on the protein at an interactive, even though not bonding, distance from Cys 303 
(the counterpart of Cys298 in the disulfide bridge) may act as an electron sink when the 
trans-thiolation between the exogenous thiol compound and the intramolecular disulfide 
takes place. This site must then be accessible to oxygen; even though no predictions can be 
made at this point for the mechanism of the electron transfer, oxygen reduction will 
ultimately be the driving force of the oxidative process. The above considerations may be 
the rationale of the insensitivity of ascorbic acid and LDL to the oxidant activity of the 
copper bound AR. 
 
 
The ability of AR to efficiently interact with copper ion leads to a stable 1:1 copper:AR 
complex in which the redox potential of the bound metal ion is preserved. Thus, following 
Cu(II) treatment, the activity of AR is switched from the aldehyde reductase activity of the 
enzyme to a thiol oxidase activity. Indeed, except for the slight, but consistent, increase in 
susceptibility of Cys-Gly to oxidation and for the significant temperature effect observed 
with Cu1-AR with respect to free copper, the pro-oxidant activity of the AR-bound metal ion 
towards thiols does not appear to be especially enhanced with respect to the free metal ion. 
On the contrary, the metal ion retained by the oxidized enzyme appears to be less active in 
triggering oxidation of non-thiol targets. In fact, ascorbate and LDL, which are very 
susceptible to the oxidation promoted by free copper ion, are essentially preserved when 
copper is bound on AR. Thus, the AR protein appears adequate in controlling the pro-
oxidant action of the metal ion in eliciting the oxidative stress phenomena of lipid 
peroxidation or ascorbate-dependent ROS generation. On the other hand, AR is apparently 
unable to buffer the redox ability of copper towards thiols. Thus, the generation of copper 
modified AR, which could occur in situations of abnormally elevated cellular copper levels, 
as those reported in Wilson disease [46] or in diabetes [47], might, through the reported 
prooxidant action of Cys and CysGly [48], ultimately promote glutathione oxidation.  
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Figure 1 Cysteine oxidation induced by copper-modified aldose reductase. Cysteine (1 mM) 
was incubated at 25°C in S-buffer in the presence of the following: none, (∇); 1 µM Cu2-
AR, (); 1 µM Cu1-AR, (▼); 1 µM CuCl2, (○); 1 µM native AR, (); solution obtained by 
ultrafiltration through an Amicon YM10 membrane of a freshly prepared 1 µM Cu2-AR, 
(); 1 µM Cu1-AR after EDTA treatment, (). At different times, residual reduced thiol 
was evaluated through Ellman titration and reported as percent of the initial value. Error bars 
represent the standard deviation from three independent measurements 
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Figure 2 Effect of cysteine concentration on the thiol oxidation rate in the presence of AR-
bound copper or free copper ion. Different concentrations of cysteine were incubated at 
25°C in 50 mM sodium phosphate buffer pH 7.4 in the presence of 0.8 µM of either Cu1-AR 
() or CuCl2 (). At different times aliquots were withdrawn and the residual reduced thiol 
was evaluated. On the basis of measurements performed at 4 different times the oxidation 
rates were calculated and reported as a function of cysteine concentration. Data are reported 
as Hanes-Woolf plot; linear regression analysis was performed in order to estimate both the 
maximal rate of oxidation and the cysteine concentration leading to half saturation 
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Figure 3 Effect of temperature on cysteine oxidation induce by AR-bound copper or free 
copper ion. Cysteine (1 mM) was incubated in 50 mM sodium phosphate buffer pH 7.4 at 
the indicated temperatures in the presence of 1 µM of either Cu1-AR () or CuCl2 (○). At 
different times aliquots were withdrawn and the residual reduced thiol was evaluated. On the 
basis of measurements performed at 4 different times the oxidation rates were calculated and 
reported as a function of cysteine concentration. Error bars (when not visible are within the 
symbol size) represent the standard deviation from three independent measurements 
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Figure 4 LDL and ascorbic acid are not oxidized by AR-bound copper. Panel a: LDL were 
incubated (70 μg/mL) in S-buffer at 37°C alone () or in the presence of 1μM of either 
CuCl2 () or Cu1-AR (). At the indicated times aliquots were withdrawn for the evaluation 
of TBA reactive compounds (see Methods). Panel b: ascorbic acid (1 mM) was incubated in 
S-buffer at 37°C alone (▲) or in the presence of 1μM of either CuCl2 () or Cu1-AR (○). At 
the indicated times aliquots were withdrawn for the evaluation of the residual ascorbic acid 
(see Methods). Error bars represent the standard deviation from three independent 
measurements 
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Table 1  
Oxidation rates of different thiols at optimal pH in the presence of Cu1-AR or CuCl2. 
Thiol compound pH Cu1-AR CuCl2 
Homocysteine 8.0 0.6 ± 0.1 0.7± 0.1 
Glutathione 8.0 0.8 ± 0.1 0.6± 0.2 
Monothioglycerol 8.0 0.8 ± 0.2 0. 8 ± 0.1 
γ-Glu-Cys 8.0 1.2 ± 0.2 1.8 ± 0.1 
β-mercaptoethanol 8.0 1.2 ± 0.1 1.0 ± 0.1 
Penicillamine 8.0/6.5 1.5 ± 0.2/1.2 ± 0.1 1.3 ± 0.2/1.6 ± 0.2 
Cysteine 7.4 23 ± 2 22 ± 2 
Cys-Gly 6.5 29 ± 5 18 ± 2 
Cysteamine 8.0 37 ± 2 30 ± 6 
Different thiols were incubated (1 mM final concentration) at 25°C in 50 mM sodium 
phosphate buffer at the indicated pH in the presence of 1 µM of either Cu1-AR or CuCl2. 
Oxidation rates (mean ± standard deviation from at least three independent measurements) 
are expressed as µM/min.  
 
